Yasushi Murata
University of Tokyo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yasushi Murata.
Journal of Human Genetics | 1998
Shinji Ishikawa; Mikio Kai; Yasushi Murata; Mayumi Tamari; Yataro Daigo; Takeshi Murano; Michio Ogawa; Yusuke Nakamura
AbstractActivins, members of a family of proteins that includes transforming growth factor-beta (TGF-beta), are gonadal polypeptide hormones that stimulate secretion of follicle-stimulating hormone (FSH). During large-scale sequencing analysis of a 1.2-Mb fragment of human genomic DNA on 3p22–p21.3, we found the gene encoding activin receptor type IIB (hActR-IIB). Comparison of its reported cDNA sequence with this genomic sequence showed that the hActR-IIB gene consists of 11 exons and spans about 30 kb of genomic DNA.
International Journal of Urology | 2006
Tsuyoshi Nakayama; Toshikazu Okaneya; Yoshiaki Kinebuchi; Yasushi Murata; Keiji Iizuka
Abstract We report a case of traumatic unilateral renal artery thrombosis that was successfully treated by thrombolytic therapy. The patient was a 17‐year‐old woman, who had put her left upper abdomen between a wall and the handle of a ground roller when using it. A computed tomography scan with intravenous contrast showed a lack of contrast in the left kidney. Angiography showed complete occlusion of the left renal artery, and the diagnosis was traumatic left renal artery thrombosis. Following angiography, thrombolytic therapy was performed. Urokinase was administered into the left renal artery, and 360 000 units per 1.5 h was required. Thrombus disappeared and flow of left renal artery was observed. Recovery of left renal function was seen on renoscintigraphy. Surgical maneuvers for traumatic renal artery thrombosis are autotransplantation or thrombectomy generally, but we think that thrombolytic therapy following angiography is a less invasive method and saves warm ischemic time.
The Japanese Journal of Urology | 2003
Toshikazu Okaneya; Shuji Nishizawa; Tsuneo Ueki; Tsuyosi Nakayama; Yoshiaki Kinebuchi; Yasushi Murata
PURPOSE The indications and the safety of non-ischemic partial nephrectomy using a microwave tissue coagulator were studied. MATERIALS AND METHODS Non-ischemic partial nephrectomy was performed on 17 kidneys of 16 patients using a microwave tissue coagulator. The diagnosis was renal tumor and renal stones in eleven and five patients, respectively. Renal tumors were less than 4 centimeters in diameter, while the stones were associated with a caliceal diverticulum or secondary cortical atrophy. Excision of the tumors was done via the retroperitoneal approach through an oblique lumbar incision. The needle of the microwave tissue coagulator was inserted around the tumor (stone) 10 to 20 times, and the coagulator was activated. Then the tumor (stone) was excised with a sharp knife or scissors. Patients were encouraged to walk on the first postoperative day. RESULTS Vascular clamping was necessary in one patient to reduce bleeding. Nephrectomy was done after partial nephrectomy in one patient because it was difficult to close the urinary collecting system after it was widely exposed. Although urine leakage was seen postoperatively in two patients, it ceased spontaneously at 14 and 23 days after surgery. Postoperative complications developed in one of seven patients (14%) with protruding renal tumor, in three of five patients (60%) with non-protruding renal tumor and in two patients with renal stone. Allogenic or autologous blood transfusion was not necessary, nor was any bleeding noticed post-operatively. In one patient, atrophy of the renal parenchyma occurred gradually after surgery and function was eventually lost. However, renal function was well preserved and recurrence of the problem was not observed in the other 15 patients, excluding one who died of esophageal cancer. CONCLUSIONS The microwave tissue coagulator is a useful surgical instrument for non-ischemic partial nephrectomy, not only in patients with renal tumors but also in patients with complicated kidney stones. However, non-protruding renal tumor in a patient with solitary kidney should be avoided for this surgery. Thermal injury to the renal parenchyma or large vessels should be avoided and urine leakage from the collecting system should be meticulously treated during the operation.
The Japanese Journal of Urology | 1996
Isao Taguchi; Toshikazu Okaneya; Takehisa Yoneyama; Kyoko Hosaka; Hirofumi Komatsu; Kazumichi Misawa; Takashi Tsuruta; Itsuki Komiyama; Hideo Kiyokawa; Yasushi Murata; Masako Kawakami
BACKGROUND Thirty-one patients with prostate cancer underwent radical prostatectomy and simultaneous pelvic lymphadenectomy at Matsumoto National Hospital between 1988 and 1994. Prognostic factors are discussed from their clincopathological findings. METHODS The patients ranged from 54 to 80-year-old, with an average age of 69.9 years. The median follow-up period was 44 months. The diagnosis was confirmed by needle biopsy or transurethral resection of the prostate. All the patients received short-term endocrine therapy preoperatively, and only noncuratively resected patients underwent adjuvant therapy postoperatively. At initial diagnosis, the tumor grades were well, moderately, and poorly differentiated adenocarcinoma in 9, 12, and 10 patients, respectively. The clinical stage was defined as A2, B, C, D1, and D2 in 12, 4, 6, 3, and 6 patients, respectively. RESULTS A difference of tumor grade was found between the initial diagnosis and the final diagnosis based on the resected prostate in 8 patients (26%), with 7 of them (88%) showing an increase in grade in the final diagnosis. Also revealed was that 11 of the 25 patients (44%) in stage A2, B, C, or D1 had been understaged preoperatively. The five-year actuarial survival rates were 100%, 92%, and 51% for patients with well, moderately, and poorly differentiated adenocarcinoma, respectively, with a significant difference noted between well and poorly differentiated adenocarcinoma (p = 0.03). Recurrence only developed in patients with pathological stage D tumors. However, the presence or absence of lymph node metastasis did not affect the crude 5-year survival rate. Several stage D patients were successfully treated by radical prostatectomy and adjuvant therapy, achieving long survival. CONCLUSION These results indicate that patients in clinical stage C have tumors which exhibit differing biological behavior. These patients should be analyzed and classified more precisely so that the most appropriate therapy can be chosen.
Human Molecular Genetics | 1994
Yasushi Murata; Mayuml Tamari; Takashi Takahashl; Yoshltsugu Horio; Kenji Hlbi; Shiro Yokoyama; Johjl Inazawa; Kazuhiro Yamakawa; Akimi Ogawa; Toshitada Takahashi; Yusuke Nakamura
DNA Research | 1999
Yataro Daigo; Minoru Isomura; Tadashi Nishiwaki; Mayumi Tamari; Shinji Ishikawa; Mikio Kai; Yasushi Murata; Kumiko Takeuchi; Yuka Yamane; Rie Hayashi; Maiko Minami; Masayuki Fujino; Yoshiaki Hojo; Ikuo Uchiyama; Toshihisa Takagi; Yusuke Nakamura
The Japanese Journal of Urology | 1999
Toshikazu Okaneya; Yasushi Murata; Yoshiaki Kinebuchi
Choonpa Igaku | 2010
Tomonori Minagawa; Yasushi Murata
The Japanese Journal of Urology | 2009
Tomonori Minagawa; Yasushi Murata; Satoshi Seki
Hinyokika kiyo. Acta urologica Japonica | 1999
Yoshiaki Kinebuchi; Toshikazu Okaneya; Yasushi Murata; Yoneyama Y